Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06658574 · ClinicalTrials.gov registry record · Phase 2
Oral Acetaminophen for Post-Op Pain Management in Bariatric Surgery Patients
A Phase 2 study of Bariatric Surgery and Post Operative Analgesia, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06658574 is a Phase 2 study of Bariatric Surgery and Post Operative Analgesia that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 150 participants, above the 89-participant average among 15 other Bariatric Surgery trials with a reported enrollment target (69% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06658574, a Phase 2 study of Bariatric Surgery and Post Operative Analgesia, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Adult patients with morbid obesity who have had Roux-en-Y gastric bypass (RYGB) or laparoscopic sleeve gastrectomy (LSG) surgery have impaired drug metabolism. There is a paucity of information available on how these patients metabolize acetaminophen post operatively and if drug preparation has any effect on achieving adequate pain control. The surgery may alter the stomach pH, reduce surface area of the stomach, affect transit time, and alter anatomic and physiologic standard absorption of medications. Due to these anatomic and physiologic changes, we seek to understand the potential effects of liquid versus pill formulations of acetaminophen on pain control in this patient population. The purpose of this study is to assess for subjective and objective measures of optimized pain control between formulations of acetaminophen including oral pills and oral liquid.
Conditions Studied
Interventions
- DRUG Acetaminophen
Study Locations (1)
New Jersey
- Robert Wood Johnson University Hospital - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-11-13 |
| Est. Completion | 2026-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06658574
The ClinicalTrials.gov registry entry for NCT06658574 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 89-participant average among 15 other Bariatric Surgery trials with a reported enrollment target (69% higher). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Bariatric Surgery appearing as the primary indexed condition, and to 1 intervention - of which Acetaminophen is the first listed.
NCT06658574 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT06658574 about?
NCT06658574 is a clinical study titled "Oral Acetaminophen for Post-Op Pain Management in Bariatric Surgery Patients". Adult patients with morbid obesity who have had Roux-en-Y gastric bypass (RYGB) or laparoscopic sleeve gastrectomy (LSG) surgery have impaired drug metabolism. There is a paucity of information available on how these patients metabolize acetaminophen post operatively and if drug preparation has any ...
What is the current status of trial NCT06658574?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2024-11-13. Estimated completion is 2026-05.
What conditions does trial NCT06658574 study?
This clinical trial studies the following conditions: Bariatric Surgery, Post Operative Analgesia, Bariatric Surgery Patients, Bariatric Surgery (Gastric Bypass), Perioperative Analgesia.
What interventions are being tested in trial NCT06658574?
The interventions under investigation include: Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT06658574?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06658574 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bariatric Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
RECRUITING · Phase 1
-
2024 Tirzepatide-Bariatric Surgery
RECRUITING · Phase 4
-
Lexion AP 50/30 Warmed Humidified Real Time CO2 Insufflation vs Airseal Recirculated CO2/Air Insufflation in Minimally Invasive Bariatric (Gastric Bypass) Surgery
RECRUITING · NA
-
Simethicone as Part of ERAS in Bariatric Surgery Patients
RECRUITING · Phase 4
-
Role of Dietary Habits in Efficacy of Bariatric Surgery - Study C
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.